NCT06779747 Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
| NCT ID | NCT06779747 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Hypothyroidism |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,850 participants |
| Start Date | 2021-12-30 |
| Primary Completion | 2041-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,850 participants in total. It began in 2021-12-30 with a primary completion date of 2041-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.
Eligibility Criteria
Inclusion Criteria: * Age older than 18 years at the time of diagnosis; * Patients with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01/01/1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase); * Obtaining informed consent. Exclusion Criteria: * Follow up lasting less than 3 months; * Incomplete or missing clinical data that may affect the correct assessment of the patient.
Contact & Investigator
Uberto Pagotto, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06779747 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypothyroidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06779747 currently recruiting?
Yes, NCT06779747 is actively recruiting participants. Contact the research team at uberto.pagotto@unibo.it for enrollment information.
Where is the NCT06779747 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06779747 clinical trial?
NCT06779747 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Uberto Pagotto, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 5,850 participants.